Upright-legged locomotion is a desirable ability for people with paraplegia. This paper introduces a newly developed lightweight powered exoskeleton (LIPE) for level walking and posture transfer of people with paraplegia using a user-centered design concept, which integrates the requirements of practical use, mechanical structure, and control system. The LIPE was evaluated with two subjects through several experimental tasks including kinematics and dynamics analysis in a local hospital. Results of functional evaluation showed that these subjects received the exoskeleton intervention well and the LIPE could provide appropriate gait assistance to the wearer during level walking, it could also help the wearer achieve the posture transfer from sitting to standing or from standing to sitting independently. Moreover, an endurance test also indicated that LIPE allows wearers to use it continuously for a long time. It is lightweight, cost effective, easy to use, and practical for people with paraplegia in their daily lives.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1109/TNSRE.2021.3118725 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Importance of the assessment of knee joint function after a stroke.
Acta Bioeng Biomech
September 2024
Department of Rehabilitation and Physiotherapy, Poznan University of Medical Sciences, Poznań, Poland.
: This study aimed to assess knee joint function in post-stroke patients using wireless motion sensors and functional tests. This type of evaluation may be important for improving gait quality. : The study included 25 post-stroke patients (age 53.
View Article and Find Full Text PDFNeuro-reproductive toxicity and carcinogenicity of 1-bromopropane - studies for evidence-based preventive medicine (EBPM).
J Occup Health
January 2025
Department of Occupational and Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Bromopropane was introduced commercially as an alternative to ozone-depleting and global warming solvents. The identification of 1-bromopropane neurotoxicity in animal experiments was followed by reports of human cases of 1-bromopropane toxicity. In humans, the most common clinical features of 1-bromopropane neurotoxicity are decreased sensation, weakness in extremities, and walking difficulties.
View Article and Find Full Text PDFProxy-reported outcomes accurately reflect objective patient-reported outcomes in older adult patients with traumatic orthopaedic injuries.
Injury
January 2025
Brigham and Women's Hospital, Department of Orthopaedic Trauma, Boston, Massachusetts, USA.
Background: Older adults make up an increasing portion of orthopedic trauma care. Proxy reports are particularly valuable when patients face difficulties formulating answers due to pre-existing or temporary cognitive impairment, and provide critical insights into patient well-being.
Questions/purposes: This study examines the agreement between patient- and proxy-reported outcome measures across various health domains of older adult orthopedic trauma patients, including those with mild cognitive impairment.
Randomized controlled trial on the efficacy of forest walking compared to urban walking in enhancing mucosal immunity.
Sci Rep
January 2025
Le Verseau Inc., Tokyo, 156-0051, Japan.
Scientific research on forest therapy's preventive medical and mental health effects has advanced, but the need for clear evidence for practical applications remains. We conducted an unblinded randomized controlled trial involving healthy men aged 40-70 to compare the physiological and psychological effects of forest and urban walking. Eighty-four participants were randomly assigned to either the forest or urban group, with 78 completing 90-min walks and analysis.
View Article and Find Full Text PDFSingle-centre, double-blinded, randomised placebo-controlled trial to determine the effect of a 12-week home-based programme of footplate neuromuscular electrical stimulation on walking capacity in people with peripheral artery disease: a protocol for the Foot-PAD trial.
BMJ Open
January 2025
College of Medicine and Dentistry, James Cook University, Queensland Research Centre for Peripheral Vascular Disease, Townsville, Queensland, Australia.
Introduction: Patients with peripheral artery disease (PAD) can experience intermittent claudication, which limits walking capacity and the ability to undertake daily activities. While exercise therapy is an established way to improve walking capacity in people with PAD, it is not feasible in all patients. Neuromuscular electrical stimulation (NMES) provides a way to passively induce repeated muscle contractions and has been widely used as a therapy for chronic conditions that limit functional capacity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!